Skip to content

Use Of Homoeopathy in Contact Dermatitis

Role Of Individualized Homoeopathic Medicine In Treatment Of Contact Dermatitis Using Homoeopathic Medical Repertory An Open Label, Prospective Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079366
Enrollment
42
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L230- Allergic contact dermatitis due tometals Health Condition 2: L240- Irritant contact dermatitis due todetergents Health Condition 3: L231- Allergic contact dermatitis due toadhesives Health Condition 4: L232- Allergic contact dermatitis due tocosmetics Health Condition 5: L233- Allergic contact dermatitis due todrugs in contact with skin Health Condition 6: L234- Allergic contact dermatitis due todyes Health Condition 7: L235- Allergic contact dermatitis due toother chem

Interventions

Intervention1: Individualized Homoeopathic medicine: Indicated individualized homoeopathic medicine will be prescribed after the repertorisation of the case using rubrics within Homoeopathic Medical r

Sponsors

National Institute of Homeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Case Of Chronic Contact Dermatitis in the Age group 18 to 65 years & of Both the sexes. Literate Patients willing to give written informed consent. Patients who can read or write or understand Hindi English Bengali. Patients already undergoing regular oral/topical conventional therapy for C.D may be recruited only if the medications are stopped completely 3 months prior to the treatment.

Exclusion criteria

Exclusion criteria: Diagnosed cases of unstable mental or psychiatric illness or uncontrolled or life-threatening illness. Pediatric age group & Lactating Women. Substance abuse & or dependence Patient under the treatment of any other therapy. Patients not willing to participate in the study. Patients not willing to undergo any investigation, if so advised.

Design outcomes

Primary

MeasureTime frame
Patient-Oriented Scoring for Atopic DermatitisTimepoint: Baseline & 6 months

Secondary

MeasureTime frame
Socio-demographic data Statical analysis Statistical InferencesTimepoint: Baseline & 6 months

Countries

India

Contacts

Public ContactDr Binod kumar bhagat

National Institute of Homeopathy

dr.binodkbhagat@gmail.com8220003741

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026